-
Je něco špatně v tomto záznamu ?
Changes in cellular prion protein expression, processing and localisation during differentiation of the neuronal cell line CAD 5
Z. Fremuntova, T. Mosko, J. Soukup, J. Kucerova, M. Kostelanska, ZB. Hanusova, M. Filipova, L. Cervenakova, K. Holada,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
NV18-04-00179
Czech Health Research Council
530217
Charles University Grant Agency
Q26/LF1
Charles University
PubMed
31736091
DOI
10.1111/boc.201900045
Knihovny.cz E-zdroje
- MeSH
- buněčná diferenciace * MeSH
- buněčné linie MeSH
- membránové mikrodomény MeSH
- myši MeSH
- neurony cytologie metabolismus MeSH
- posttranslační úpravy proteinů MeSH
- priony metabolismus MeSH
- PrPC proteiny metabolismus MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND INFORMATION: Cellular prion protein (PrPC ) is infamous for its role in prion diseases. The physiological function of PrPC remains enigmatic, but several studies point to its involvement in cell differentiation processes. To test this possibility, we monitored PrPC changes during the differentiation of prion-susceptible CAD 5 cells, and then we analysed the effect of PrPC ablation on the differentiation process. RESULTS: Neuronal CAD 5 cells differentiate within 5 days of serum withdrawal, with the majority of the cells developing long neurites. This process is accompanied by an up to sixfold increase in PrPC expression and enhanced N-terminal β-cleavage of the protein, which suggests a role for the PrPC in the differentiation process. Moreover, the majority of PrPC in differentiated cells is inside the cell, and a large proportion of the protein does not associate with membrane lipid rafts. In contrast, PrPC in proliferating cells is found mostly on the cytoplasmic membrane and is predominantly associated with lipid rafts. To determine the importance of PrPC in cell differentiation, a CAD 5 PrP-/- cell line with ablated PrPC expression was created using the CRISPR/Cas9 system. We observed no considerable difference in morphology, proliferation rate or expression of molecular markers between CAD 5 and CAD 5 PrP-/- cells during the differentiation initiated by serum withdrawal. CONCLUSIONS: PrPC characteristics, such as cell localisation, level of expression and posttranslational modifications, change during CAD 5 cell differentiation, but PrPC ablation does not change the course of the differentiation process. SIGNIFICANCE: Ablation of PrPC expression does not affect CAD 5 cell differentiation, although we observed many intriguing changes in PrPC features during the process. Our study does not support the concept that PrPC is important for neuronal cell differentiation, at least in simple in vitro conditions.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023266
- 003
- CZ-PrNML
- 005
- 20211014095208.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/boc.201900045 $2 doi
- 035 __
- $a (PubMed)31736091
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fremuntova, Zuzana $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 245 10
- $a Changes in cellular prion protein expression, processing and localisation during differentiation of the neuronal cell line CAD 5 / $c Z. Fremuntova, T. Mosko, J. Soukup, J. Kucerova, M. Kostelanska, ZB. Hanusova, M. Filipova, L. Cervenakova, K. Holada,
- 520 9_
- $a BACKGROUND INFORMATION: Cellular prion protein (PrPC ) is infamous for its role in prion diseases. The physiological function of PrPC remains enigmatic, but several studies point to its involvement in cell differentiation processes. To test this possibility, we monitored PrPC changes during the differentiation of prion-susceptible CAD 5 cells, and then we analysed the effect of PrPC ablation on the differentiation process. RESULTS: Neuronal CAD 5 cells differentiate within 5 days of serum withdrawal, with the majority of the cells developing long neurites. This process is accompanied by an up to sixfold increase in PrPC expression and enhanced N-terminal β-cleavage of the protein, which suggests a role for the PrPC in the differentiation process. Moreover, the majority of PrPC in differentiated cells is inside the cell, and a large proportion of the protein does not associate with membrane lipid rafts. In contrast, PrPC in proliferating cells is found mostly on the cytoplasmic membrane and is predominantly associated with lipid rafts. To determine the importance of PrPC in cell differentiation, a CAD 5 PrP-/- cell line with ablated PrPC expression was created using the CRISPR/Cas9 system. We observed no considerable difference in morphology, proliferation rate or expression of molecular markers between CAD 5 and CAD 5 PrP-/- cells during the differentiation initiated by serum withdrawal. CONCLUSIONS: PrPC characteristics, such as cell localisation, level of expression and posttranslational modifications, change during CAD 5 cell differentiation, but PrPC ablation does not change the course of the differentiation process. SIGNIFICANCE: Ablation of PrPC expression does not affect CAD 5 cell differentiation, although we observed many intriguing changes in PrPC features during the process. Our study does not support the concept that PrPC is important for neuronal cell differentiation, at least in simple in vitro conditions.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a membránové mikrodomény $7 D021962
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a neurony $x cytologie $x metabolismus $7 D009474
- 650 _2
- $a PrPC proteiny $x metabolismus $7 D018621
- 650 _2
- $a priony $x metabolismus $7 D011328
- 650 _2
- $a posttranslační úpravy proteinů $7 D011499
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mosko, Tibor $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Soukup, Jakub $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Department of Genetics and Microbiology, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Kucerova, Johanka $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Kostelanská, Marie, $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. $d 1988- $7 xx0264879
- 700 1_
- $a Hanusova, Zdenka Backovska $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Filipova, Marcela $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 700 1_
- $a Cervenakova, Larisa $u Plasma Protein Therapeutics Association, Annapolis, Maryland, USA.
- 700 1_
- $a Holada, Karel $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00000749 $t Biology of the cell $x 1768-322X $g Roč. 112, č. 1 (2020), s. 1-21
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31736091 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20211014095206 $b ABA008
- 999 __
- $a ok $b bmc $g 1595585 $s 1113942
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 112 $c 1 $d 1-21 $e 20191206 $i 1768-322X $m Biology of the cell $n Biol Cell $x MED00000749
- GRA __
- $a NV18-04-00179 $p Czech Health Research Council
- GRA __
- $a 530217 $p Charles University Grant Agency
- GRA __
- $a Q26/LF1 $p Charles University
- LZP __
- $a Pubmed-20201125